| Description | This product is a human monoclonal antibody that reacts with HLA-DRA. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation. Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Human |
| Immunogen | BALB/c-derived mutant B lymphoma line M12.C3, transfected with chimeric human/mouse class II gene. |
| Epitope | Located in the first HLA-DR domains. |
| Isotype | IgG2 kappa |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
| Endotoxin | <1 EU/mg, determined by LAL method |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
| Application | Apop; IF |
| Application Notes | The antibody is recommended for detection of HLA-DRA by Apop, IF (1/100-1/500) assays. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | HLA-DRA |
| Alternative Name | Major Histocompatibility Complex, Class II, DR Alpha; MHC Class II Antigen DRA; HLA-DRA1; HLA Class II Histocompatibility Antigen, DR Alpha Chain; Histocompatibility Antigen HLA-DR Alpha; Chimeric DN-1924; Chimeric DN1924 |
| Gene ID | 3122 |
| UniProt | P01903 |
| Research Area | Immunology |
